In this light, Q-MSP results of the multiplex assay were tested in decreasing amounts of biopsy sections. To this end, biopsies consisting of 10, 20 and 40 μm from FFPE tissue blocks from the ...

Further adoption of TMAs into the clinical laboratory is likely to be driven by adoption of both digital pathology and/or the use of quantitative tissue-based assays. TMAs can serve as useful ...

The Maryland-based firm said that the money will support the development and commercialization of a screening test for esophageal squamous cell carcinoma.

Yoshiaki Nakamura, MD, PhD, discusses how the use of tissue-free circulating tumor DNA (ctDNA) analysis for detecting minimal residual disease (MRD) can enhance the prediction of recurrence in stage ...

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

MeiraGTx (MGTX) announced the Company will exhibit five posters at the European Society of Gene and Cell Therapy, ESGCT, 2024 Annual Congress, ...

The Gaublomme lab has developed a new optical pooled screening approach called CRISPRmap, which enables the coupling of ...

These are tissue-specific bispecific antibodies in ... the limitations of current therapeutic modalities using cell-based assays that evaluate critical markers, including EGFR antagonism ...

Morgan Stanley analyst Tejas Savant maintained a Hold rating on Hologic (HOLX – Research Report) today and set a price target of $84.00.

with AI-based image analysis In Carta software (analysis mask shown in purple). Image Credit: Molecular Devices UK Ltd Organoid assay and compound treatment was automated via ...